Keep Informed on Legal and Compliance Developments Affecting Diagnostic Labs
Best practices and expert insight to help lab professionals comply with regulations and identify strategic trends in business and technology
Already a Subscriber? Log in Here
Lab Industry Advisor Subscription
Struggling with Staying Informed? In the fast-paced world of diagnostic medicine, staying updated with the latest legal, compliance, regulatory, and industry insights is crucial. Yet, finding reliable and comprehensive information can be overwhelming and time-consuming.
Lab Industry Advisor to the Rescue! Lab Industry Advisor provides comprehensive, up-to-date insights and analyses tailored to your needs. With expert commentary and actionable advice, you’ll stay ahead of the curve. No more sifting through endless sources—everything you need is right here!
Start your free trial today and see how Lab Industry Advisor can transform your approach. Get instant access to invaluable resources designed to keep you informed and competitive. Explore detailed reports, in-depth articles, and exclusive industry insights that help you make better decisions faster. Choose from three subscription levels tailored to fit your needs: Essential, Premium, and Elite.
Additional Business Intelligence Offerings
Lab Industry Advisor Subscriptions Include
Analysis and insight on key compliance, legal, and business developments affecting laboratories
- Updates on changes to regulations
- Healthcare-related laws
- FDA approvals
- Business deals in the diagnostics space, and more
Latest Articles
LDTs Rule Update: More Support for Legal Challenges Against FDA
Key clinical laboratory organizations file amicus brief, reiterating that the FDA is overstepping its authority, and its new rule would cause “irreparable patient harm”
Expert Q&A: Lessons Learned from a Total Laboratory Automation Project
Clinical Microbiology division head Jeff Fuller, FCCM, discusses his clinical laboratory’s recent automation transformation and offers tips to ensure success
CDC Releases Recommendations to Address Rising Syphilis Cases
Key updates from the CDC’s new lab recommendations for syphilis testing.
A Debate—Resolved: Immunohistochemistry Should Be Regulated As An Assay
Join G2 Intelligence for this interactive discussion about whether clinical immunohistochemistry testing should be a stain or an assay, with our experts offering arguments for and against the proposed changes
Lab Institute Virtual Event: Finding Opportunities to Maximize Efficiency
Our event provides lab leaders with strategies to boost their lab's efficiency and improve their organization's bottom line
FDA Watch: New Test for Esophageal Conditions is Coming to the US
UK-developed assay that uses a sponge appears to reduce the need for more invasive endoscopies.
Dx Deals: Quest and Labcorp Move beyond Laboratory Testing
Both companies have made recent moves to diversify further.
Diagnostics Pipeline: More AI-Reliant Platforms Being Approved by the FDA
Such assays rely more on imaging and computer power than tissue samples to make diagnoses.
Special Report: 5 Lab Kickback Risks Involving Incentives
Strategies to avoid compliance issues related to registries, space rentals, and other common incentives.
Boosting Retention and Hiring in Medical Laboratories
Key reasons for continued staffing shortages and tips for addressing these issues to support current staff and attract new talent.
We’ve Lost Our Lab Director, Now What?
Key steps to successfully navigate a CLIA laboratory director transition and select the best possible replacement for your organization.